首页|期刊导航|Hepatobiliary & Pancreatic Diseases International|The outcomes of surgical resection versus ablation of liver metastases from neuroendocrine tumors:A systematic review

The outcomes of surgical resection versus ablation of liver metastases from neuroendocrine tumors:A systematic reviewOA

中文摘要

Background:Neuroendocrine liver metastases(NLMs)from gastroenteropancreatic neuroendocrine tu-mors(GEP-NETs)significantly impact morbidity and mortality.While surgical resection remains the stan-dard treatment,radiofrequency ablation(RFA)has emerged as an alternative for unresectable cases.This systematic review compared the oncological outcomes of surgical resection and RFA.Data sources:A systematic search of PubMed,Web of Science,and Scopus identified studies published between 2014 and 2025.Eligible studies were screened,data extracted and assessed for bias using the Cochrane Risk of Bias tool and the Methodological Index for Non-randomized Studies(MINORS)crite-ria.Primary outcomes were overall survival(OS)and recurrence-free survival(RFS).Secondary outcomes included complication rates and hospital stay duration.Results:Four studies with 238 patients met the inclusion criteria.Of these,120(50.4%)underwent resec-tion,67(28.2%)RFA,19(8.0%)combined treatment,and the remaining not reported.Two studies reported comparable OS,while one favored resection(160 vs.123 months,P<0.001).RFS differences were not significant.RFA had fewer complications and a shorter hospital stay(3.8 vs.14.9 days,P<0.001).Bias risk was moderate to high.Conclusions:RFA is a safe,less invasive alternative to resection but requires further study to determine long-term efficacy.Standardized,multi-center trials are needed.

Clement Yong Jing Cheng;Nur Shawky;Joachim Ho;Parth Tagdiwala;Rohaan Shahzad;Panagis Lykoudis

University College London Medical School,London,UKUniversity College London Medical School,London,UKUniversity College London Medical School,London,UKUniversity College London Medical School,London,UKUniversity College London Medical School,London,UKDivision of Surgery&Interventional Science,London,UK

医药卫生

Liver metastasesNeuroendocrine neoplasmsNeuroendocrine tumorsSurgical resectionAblation

《Hepatobiliary & Pancreatic Diseases International》 2026 (4)

P.375-381,7

10.1016/j.hbpd.2026.05.004

评论